USMJ Reports 12% Revenue Growth With $225,000 In Sales For The Period Ended September 30th 2018
November 20 2018 - 9:39AM
InvestorsHub Cannabis NewsWire
Dallas, TX --
November 20, 2018 -- InvestorsHub NewsWire -- North American Cannabis Holdings, Inc. (USOTC:
USMJ) (“USMJ”) today announced filing its first quarter
financial report for the period ended September 30th,
2018. The company reported $225,000 in revenue compared
to $201,000 in revenue for the same period last year.
Management attributes the 12% increase in revenue to organic
growth.
USMJ recently announced a series of
transactions and events amounting to a business restructuring to
ultimately result in USMJ evolving into an online, cannabis sector
ecommerce business. USMJ has published a presentation on the
company’s website to detail the recently
announced spinoff of its AmeriCanna Cafe business in a transaction
with Priority Aviation (USOTC:
PJET) (“PJET”). The
presentation includes details on AmeriCanna Cafe’s partnership with
West Coast Venture Group (OTCQB:
WCVC) (“WCVC”) the owner and
operator of the $3 million Colorado based Illegal Burger
chain. More information is already available online regarding
the related sale of PJET’s Telluride Health Company to Puration,
Inc. (USOTC:
PURA) (“PURA”)
at https://www.purationinc.com/thc.
The online presentation is available on the company’s website
at https://www.growusmj.com/usmjpjetwcvc-presentation.
Learn more about USMJ at www.growusmj.com
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Steven
Rash
CEO North American Cannabis Holdings,
Inc.
info@aciconglomerated.com
+1-800-861-1350
Priority Aviation (CE) (USOTC:PJET)
Historical Stock Chart
From Sep 2024 to Oct 2024
Priority Aviation (CE) (USOTC:PJET)
Historical Stock Chart
From Oct 2023 to Oct 2024